ABO incompatible kidney transplantation on triple therapy compared with quadruple therapy.
Aikawa
A
A
Department of Nephrology, Toho University, Tokyo, Japan.
Ohara
T
T
Hasegawa
A
A
Yamashita
M
M
Hadano
T
T
Shindo
M
M
Mizuiri
T
T
Fushimi
T
T
Sakai
K
K
Hirayama
N
N
Arai
K
K
Tajima
E
E
D000017:ABO Blood-Group System; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis
D000017:ABO Blood-Group System; D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; C037258:gusperimus; D008775:Methylprednisolone